1,872
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy

, , , , , , , & ORCID Icon show all
Article: 1770565 | Received 04 Oct 2019, Accepted 05 May 2020, Published online: 02 Jun 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.